AQP7 has been associated with multiple disease states, including obesity, insulin resistance, and thyroid and breast cancers, indicating the potentially broad clinical application of an AQP7-selective modulator [11,20,21,22,23,24,25,26,27,28,29]. Here, AQP7 is linked to Insulin resistance.